Neopen Suspension for Injection

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Neomycin sulphate; Procaine benzylpenicillin

から入手可能:

Intervet Ireland Limited

ATCコード:

QJ01RA01

INN（国際名）:

Neomycin sulphate; Procaine benzylpenicillin

投薬量:

100/200 milligram(s)/millilitre

医薬品形態:

Suspension for injection

処方タイプ:

POM: Prescription Only Medicine as defined in relevant national legislation

治療群:

Cattle, Horses, Pigs

治療領域:

penicillins, combinations with other antibacterials

適応症:

Antibacterial

認証ステータス:

Authorised

承認日:

1987-10-01

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Neopen Suspension for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substances
Procaine benzylpenicillin
200 mg
Neomycin (as neomycin sulphate)
100 mg
Excipients
Methylparahydroxybenzoate (E218)
1.1 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs and horses
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infections caused by organisms which are
susceptible to neomycin/penicillin combinations.
In cattle and pigs, including pasteurellosis, mastitis, metritis,
enteric and urinary tract infections. Sensitive
organisms include:_ Streptococcus_ and_ Staphylococcus_ spp, some_
E_._coli_ and some_ Salmonella_ spp.
In horses, especially those infections associated with_ Streptococcus_
spp. and_ Staphylococcus_ spp.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to penicillin or neomycin or to
any of the excipients.
Do not administer by the intravenous route.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_3_
_2_
_8_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering